Clinical Trial Update: SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating early infusion of vitamin C for treating acute lung injury in COVID-19; study completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: COVID-19, Lung Injury, Acute | Phase 2 | Status: COMPLETED | Results posted: 2024-04-04